Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 1531108)

1.

In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release.

Baldwin AD, Robinson KG, Militar JL, Derby CD, Kiick KL, Akins RE Jr.

J Biomed Mater Res A. 2012 Aug;100(8):2106-18. doi: 10.1002/jbm.a.34050. Epub 2012 May 21.

2.

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH; American College of Chest Physicians.

Chest. 2012 Feb;141(2 Suppl):e152S-84S. doi: 10.1378/chest.11-2295. Review.

3.

Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis.

Estrada CA, Mansfield CJ, Heudebert GR.

J Gen Intern Med. 2000 Feb;15(2):108-15.

4.

Anticoagulation in venous thrombosis.

Schulman S.

J R Soc Med. 1996 Nov;89(11):624-30. Review.

6.

Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders.

Anderson DR, Fernandez LA.

Can Fam Physician. 1993 Feb;39:290-4, 297-300, 303-4. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk